Evans M, Chubb B, Malkin SJ, Berry S, et al. Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11. Diabetes Obes Metab 2022 Oct 17. doi: 10.1111/dom.14892.
PMID: 36251282